Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 14, 2024

SELL
$23.0 - $31.59 $345 - $473
-15 Closed
0 $0
Q3 2022

Aug 14, 2024

BUY
$28.74 - $39.9 $431 - $598
15 New
15 $450,000
Q2 2019

Aug 30, 2024

SELL
$83.92 - $108.88 $41,960 - $54,440
-500 Closed
0 $0
Q1 2019

Aug 30, 2024

BUY
$85.97 - $108.09 $42,985 - $54,045
500 New
500 $54 Million
Q1 2018

Aug 30, 2024

SELL
$95.91 - $107.26 $14,386 - $16,089
-150 Closed
0 $0
Q1 2017

Aug 30, 2024

BUY
N/A
150
150 $17.5 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.